Higher interest rates are worsening a persistent issue in private equity: zombie funds. These funds hold struggling companies that cannot be sold or revived. They tie up investor capital for years beyond their expected lifespan.
Zombie funds typically emerge when portfolio companies fail to meet growth targets. Managers keep them alive through extensions and small capital infusions. Higher borrowing costs now make this strategy more expensive and risky.
The problem has grown as rates stay elevated. Many buyout deals from the low-rate era now struggle to refinance debt. Lenders demand stricter terms, leaving fewer exit options for weak companies.
Investors face limited returns and prolonged fee payments. Capital trapped in zombie funds cannot be redeployed into new opportunities. This drags on overall private equity performance.
Fund managers often resist writing down these assets. They hope for a market recovery or a last-minute sale. But prolonged uncertainty erodes trust with limited partners.
Some funds use continuation vehicles to shift assets to new investors. Regulators scrutinize these moves for potential conflicts of interest. Transparency remains a key concern for pension funds and endowments.
In a separate development, A-CAP insurers sued South Carolina’s regulator. The lawsuit challenges the state’s takeover attempt of the insurance group. A-CAP argues the action is unjustified and harms policyholders.
The lawsuit adds pressure to an already tense regulatory environment. State insurance departments are increasingly assertive with troubled firms. A-CAP’s case could set a precedent for similar disputes.
Both stories highlight broader stress in leveraged finance. Higher rates expose weak business models and aggressive deal structures. Investors and regulators are watching closely as risks mount.
